Obesity and the risk for premenopausal and postmenopausal breast cancer
- PMID: 22392012
- DOI: 10.1158/1940-6207.CAPR-12-0091
Obesity and the risk for premenopausal and postmenopausal breast cancer
Abstract
Obesity has been consistently associated with an increased risk of postmenopausal breast cancer in population-based studies. Conversely, obesity in such studies has been inversely associated with premenopausal breast cancer risk. In a report of data from two large chemoprevention trials, both of which enrolled women at a high risk of breast cancer, obesity was associated with only a modest, nonsignificantly increased risk of postmenopausal breast cancer and a surprising statistically significant 70% increased risk of premenopausal breast cancer (vs. normal weight). The discrepancies between these results and those from previous observational studies may be due to differences in study design and exposure ascertainment or due to inherent biologic differences whereby the obesity-breast cancer association differs for high-risk women in the clinical setting compared with general population, average-risk women in the observational setting.
2012 AACR
Similar articles
-
Biomarkers associated with breast cancer are associated with obesity.Cancer Detect Prev. 2008;32(2):149-55. doi: 10.1016/j.cdp.2008.06.002. Epub 2008 Jul 17. Cancer Detect Prev. 2008. PMID: 18639389
-
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):681-7. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10919738
-
Body weight and risk of breast cancer in BRCA1/2 mutation carriers.Breast Cancer Res Treat. 2011 Feb;126(1):193-202. doi: 10.1007/s10549-010-1120-8. Epub 2010 Aug 21. Breast Cancer Res Treat. 2011. PMID: 20730487
-
Interaction between menopausal status and obesity in affecting breast cancer risk.Maturitas. 2010 May;66(1):33-8. doi: 10.1016/j.maturitas.2010.01.019. Epub 2010 Feb 23. Maturitas. 2010. PMID: 20181446 Review.
-
Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.Breast Cancer Res Treat. 2010 Oct;123(3):641-9. doi: 10.1007/s10549-010-1116-4. Epub 2010 Aug 15. Breast Cancer Res Treat. 2010. PMID: 20711809 Review.
Cited by
-
Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer.J Cancer. 2021 May 27;12(15):4488-4496. doi: 10.7150/jca.59133. eCollection 2021. J Cancer. 2021. PMID: 34149912 Free PMC article.
-
Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis.Genet Test Mol Biomarkers. 2014 Jun;18(6):417-24. doi: 10.1089/gtmb.2013.0493. Epub 2014 Apr 10. Genet Test Mol Biomarkers. 2014. PMID: 24720830 Free PMC article.
-
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.Breast Cancer Res Treat. 2021 Nov;190(1):69-78. doi: 10.1007/s10549-021-06355-9. Epub 2021 Aug 12. Breast Cancer Res Treat. 2021. PMID: 34383179 Free PMC article. Clinical Trial.
-
Hyperresistinemia and metabolic dysregulation: a risky crosstalk in obese breast cancer.Endocrine. 2016 Aug;53(2):433-42. doi: 10.1007/s12020-016-0893-x. Epub 2016 Feb 18. Endocrine. 2016. PMID: 26892376
-
Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation.Endocrine. 2013 Oct;44(2):496-503. doi: 10.1007/s12020-013-9897-y. Epub 2013 Feb 15. Endocrine. 2013. PMID: 23412922
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical